Used in organic synthesis as a key intermediate for the development of pharmaceuticals, particularly in the creation of kinase inhibitors that target specific enzymes involved in disease pathways. Its boronic acid group facilitates Suzuki-Miyaura cross-coupling reactions, enabling the formation of carbon-carbon bonds essential for constructing complex molecules. This compound is also employed in the design of bioactive molecules for research in cancer therapy and neurodegenerative diseases, leveraging its ability to interact with biological targets effectively. Additionally, it serves as a building block in medicinal chemistry for optimizing drug candidates with improved potency and selectivity.